Strategies for rescue therapy

Antiviral Therapy

Volumn 3, Issue SUPPL. 4, 1998, Pages 75-77

  Lange, Joep M A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS RESISTANCE;

HIV INFECTIONS; HUMANS; HYDROXYUREA; SALVAGE THERAPY;

EID: 0031744066     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Fätkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C, Becker K, Wieland U, Pfister H, Reiser M, Hegener P, Franzen C, Schwenk A & Salzberger B. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 1997; 11:F113-116.
2. d'Arminio Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M & Moroni M Clinical outcome and predictive factors of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV infection. AIDS 1998; 12:1631-1637.
3. Wit FWNM, van Leeuwen R, Weverling GJ et al. Outcome and predictors of failure of highly active antiretroviral therapy: one year follow-up of a cohort of HIV-1 infected indivuduals. Journal of Infectious Diseases 1998; (in press).
4. Wong JK, Günthard HF, Havlir DV et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologie outcomes of treatment failure. Proceedings of the National Academy of Sciences, USA 1997; 94:12574-12579.
5. Lange JMA. Current problems and the future of antiretroviral drug trials. Science 1997; 276:548-550.